Psychedelic stocks = super-risky biotechs low on cash. Make small bets.
Descarga y escucha en cualquier lugar
Descarga tus episodios favoritos y disfrútalos, ¡dondequiera que estés! Regístrate o inicia sesión ahora para acceder a la escucha sin conexión.
Descripción
Analyst https://seekingalpha.com/author/alexander-carchidi?source=cip_podcast:psychedelic_stocks_super_risky_biotechs_low_on_cash returns to update investors on the psychedelics industry. This is the full conversation of an interview originally published on https://seekingalpha.com/article/4616920-psychedelic-stocks-dont-bet-on-just-1-company?source=cip_podcast:psychedelic_stocks_super_risky_biotechs_low_on_cash. - (2:50) Industry's collapse and consolidation - (5:00)...
mostra más- (2:50) Industry's collapse and consolidation
- (5:00) Compass Pathways timeline for clinical trials
- (15:00) Super-risky biotech companies low on cash - don't bet on just 1 company
- (21:20) Atai and Cybin's recent wins
- (32:55) Ketamine clinics and viable business models
Cybin: A Leading Early-Stage Psychedelics Play
Psychedelic Sunday: Mushrooms Are The Key - Red Light Holland CEO Todd Shapiro
Numinus CEO Payton Nyquvest On Transforming Healthcare With Psychedelics
Podcast transcripts on Seeking Alpha
Cannabis Investing Podcast Twitter
Información
Autor | Seeking Alpha |
Organización | Seeking Alpha |
Página web | seekingalpha.com |
Etiquetas |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company